Similar articles

• Outpatient management of febrile neutropenia: is it safe yet?

  Johnson TN, DeJesus YA, McMahon L, Rolston KV, Row MB. Johnson TN, et al. J Support Oncol. 2008 May-Jun;6(5):219-20. J Support Oncol. 2008. PMID: 18551857 No abstract available.
• Outpatient management of febrile neutropenia: time to revise the present treatment strategy.

  Carstensen M, Sørensen JB. Carstensen M, et al. J Support Oncol. 2008 May-Jun;6(5):199-208. J Support Oncol. 2008. PMID: 18551855 Review.
• Management of febrile neutropenia in pediatric oncology patients: a Canadian survey.

  Boragina M, Patel H, Reiter S, Dougherty G. Boragina M, et al. Pediatr Blood Cancer. 2007 May;48(5):521-6. doi: 10.1002/pbc.20810. Pediatr Blood Cancer. 2007. PMID: 16724314
• Outpatient oral antibiotics for febrile neutropenic cancer patients.

  Ouvrier MJ, Thery JC, Blot E. Ouvrier MJ, et al. J Clin Oncol. 2006 Dec 10;24(35):5614; author reply 5614-5. doi: 10.1200/JCO.2006.09.0571. J Clin Oncol. 2006. PMID: 17158551 No abstract available.
• New trends in patient management: risk-based therapy for febrile patients with neutropenia.

  Rolston KV. Rolston KV. Clin Infect Dis. 1999 Sep;29(3):515-21. doi: 10.1086/598624. Clin Infect Dis. 1999. PMID: 10530438 Review.